6533b859fe1ef96bd12b7cb2

RESEARCH PRODUCT

“Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”

Gfilippelli CsandomenicoAfarris BmassiddaDnataleGcondemi LmaiorinoEgreco SleoAgambardellaSergio Palmeri

subject

http://hdl.handle.net/10447/29366